APA (7th ed.) Citation

Liang, G., Liu, X., Gao, M., Yang, B., Song, Y., & Liu, Q. (2025). A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System. Pharmacology Research & Perspectives, 13(6), 1. https://doi.org/10.1002/prp2.70194

Chicago Style (17th ed.) Citation

Liang, Guojun, Xiaofang Liu, Mengge Gao, Bo Yang, Yang Song, and Qiong Liu. "A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System." Pharmacology Research & Perspectives 13, no. 6 (2025): 1. https://doi.org/10.1002/prp2.70194.

MLA (9th ed.) Citation

Liang, Guojun, et al. "A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System." Pharmacology Research & Perspectives, vol. 13, no. 6, 2025, p. 1, https://doi.org/10.1002/prp2.70194.